Advanced CGTs are expanding to larger patient populations, requiring strategic distribution approaches centered on patient needs. Effective channel strategies, broadening access, and reducing ...
Eli Lilly will submit orforglipron to be part of FDA’s new national priority voucher program, according to a new report. 1 ...
HHS Secretary Kennedy stated there is insufficient evidence to link Tylenol to autism, conflicting with the Texas lawsuit.
The GCC is becoming a strategic anchor for global venture capital, with Riyadh emerging as a key fundraising hub. Sovereign ...
PE: What policy incentives are created by FDA's ANDA Prioritization Pilot? Botha: Right now, we’re seeing multiple efforts ...
Thermo Fisher Scientific is set to acquire Clario Holdings after entering a $8.8 billion definitive agreement, which includes ...
GSK is set to acquire the exclusive rights for Syndivia’s preclinical antibody-drug conjugate (ADC), which is currently in ...
Shortly following the announcement of its acquisition of Syndivia’s ADC, GSK entered into a worldwide exclusive license ...
The agency announced new draft guidance to simplify biosimilarity studies and reduce clinical testing that it has deemed ...
PE: What impact will FDA's ANDA Prioritization Pilot have on efficiency and competitiveness? Botha: Setting up new ...
Organon announced that CEO Kevin Ali intends to resign from his position following results from an internal investigation ...
In today’s Pharmaceutical Executive Daily, we cover Thermo Fisher’s $8 billion agreement to acquire Clario Holdings, Eli ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback